Stock PHO PHOTOCURE ASA
Add to a list
To use this feature you must be a member
Log inSign up

Company Photocure ASA

Equities

PHO

NO0010000045

Pharmaceuticals

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-04-25 am EDT 		5-day change 1st Jan Change
54.4 NOK 0.00% Intraday chart for Photocure ASA +1.12% -19.29%
Apr. 08 Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France CI
Mar. 28 Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy CI

Business Summary

Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.

Number of employees: 88

Sales per Business

NOK in Million2021Weight2022Weight Delta
Commercial Franchise
100.0 %
352 99.5 % 374 100.0 % +6.30%

Sales per region

NOK in Million2021Weight2022Weight Delta
United States
39.8 %
125 35.4 % 149 39.8 % +19.02%
Germany
39.8 %
142 40.1 % 149 39.8 % +4.94%
France
7.2 %
29 8.2 % 27 7.2 % -6.85%
Nordic Countries
6.0 %
32 9.0 % 23 6.0 % -28.97%
Austria
2.5 %
9 2.5 % 10 2.5 % +5.76%
BENELUX
1.2 %
-- 5 1.2 % -
Italy
1.2 %
2 0.5 % 4 1.2 % +156.94%
Other European Countries
1.0 %
4 1.1 % 4 1.0 % -3.17%
United Kingdom
0.6 %
3 1.0 % 2 0.6 % -37.73%
Canada
0.5 %
-- 2 0.5 % -
Partner Countries Rest of World
0.1 %
2 0.6 % 1 0.1 % -75.06%

Managers

Managers TitleAgeSince
Daniel Schneider CEO
 Chief Executive Officer - 18-10-31
Erik Dahl DFI
 Director of Finance/CFO - 12-08-14
Anders Neijber CTO
 Chief Tech/Sci/R&D Officer - 21-07-31
Patricia Kelly HRO
 Human Resources Officer - 20-08-31
Susanne Strauss PRN
 Corporate Officer/Principal - 20-06-30
Grete Hogstad SAM
 Sales & Marketing 68 05-01-31
Geoffrey Coy PRN
 Corporate Officer/Principal - 19-09-30

Members of the board

Members of the board TitleAgeSince
Johanna Holldack BRD
 Director/Board Member - 17-04-27
Malene Brondberg BRD
 Director/Board Member 51 -
Dylan Hallerberg CHM
 Chairman - -
Neal Shore BRD
 Director/Board Member - 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,120,820 26,660,866 ( 98.30 %) 15,122 ( 0.0558 %) 98.30 %

Shareholders

NameEquities%Valuation
Briarwood Chase Management LLC
14.23 %
3,858,039 14.23 % 20 M kr
Lannebo Fonder AB
6.615 %
1,794,000 6.615 % 9 M kr
KLP Kapitalforvaltning AS
5.574 %
1,511,704 5.574 % 8 M kr
Pengana Capital Ltd.
5.482 %
1,486,710 5.482 % 8 M kr
SEB Investment Management AB
4.930 %
1,337,101 4.930 % 7 M kr
Radiumhospitalets Forskningsstiftelse
2.506 %
679,619 2.506 % 3 M kr
SAGA Asset Management AS
2.099 %
569,200 2.099 % 3 M kr
MP Pensjon PK
1.763 %
478,026 1.763 % 2 M kr
Eika Kapitalforvaltning AS
0.9497 %
257,565 0.9497 % 1 M kr
Fondsfinans Kapitalforvaltning AS
0.8639 %
234,303 0.8639 % 1 M kr

Holdings

NameEquities%Valuation
PHOTOCURE ASA
0.06%
 15,122 0.06% 77,087 $

Company contact information

Photocure ASA

Hoffsveien 4

0275, Oslo

+47 22 06 22 10

http://ww.photocure.no
address Photocure ASA(PHO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Photocure ASA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
54.4 NOK
Average target price
86 NOK
Spread / Average Target
+58.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PHOTOCURE ASA Stock Photocure ASA
-19.29% 134M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-12.26% 149B
AMGEN INC. Stock Amgen Inc.
-6.47% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PHO Stock
  4. Company Photocure ASA